UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


_______________

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

 

May 30, 2013 (May 30, 2013)

_______________

 

HARRIS & HARRIS GROUP, INC.

 

 (Exact name of registrant as specified in its charter)

         
New York
(State or other jurisdiction of
incorporation)		   0-11576
(Commission File
Number)		   13-3119827
(IRS Employer
Identification No.)

 

1450 Broadway
New York, New York 10018 

 

 (Address of principal executive offices and zip code)

 

(212) 582-0900

 

 (Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

 

Item 8.01. Other Events.

 

On May 30, 2013, Harris & Harris Group, Inc. (the “Company”) noted that Health Diagnostic Laboratory, Inc. ("HDL"), a CLIA-certified laboratory specializing in advanced cardiovascular and metabolic disease testing and health management, has launched a new blood test for stratifying prediabetic patients based on the Quantose™ insulin resistance markers discovered by Metabolon, Inc. The Company is an investor in privately held Metabolon. The Company’s press release is attached hereto as Exhibit 99.1.

 

Item 9.01. Financial Statements and Exhibits.

 

(a)Not applicable.

 

(b)Not applicable.

 

(c)Not applicable.

 

(d)Exhibits.

 

Exhibit No. Description
   
99.1 Press Release dated May 30, 2013

 

 
 

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date: May 30, 2013 HARRIS & HARRIS GROUP, INC.
   
   
   
  By: /s/ Douglas W. Jamison
        Douglas W. Jamison
        Chief Executive Officer

 

 
 

  

 

EXHIBIT INDEX

 

Exhibit No. Description
   
99.1 Press Release dated May 30, 2013